share_log

Kiniksa Pharmaceuticals | DEF 14A: Definitive proxy statements

SEC announcement ·  Apr 27, 2023 16:43
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more